scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Paying Medicare Advantage plans: To level or tilt the playing field.

01 Dec 2017-Journal of Health Economics (J Health Econ)-Vol. 56, pp 281-291
TL;DR: In areas where the MA market is competitive, the benchmark should be set below average costs in TM, but in areas characterized by imperfect competition in MA, it should be raised in order to offset output (enrollment) restrictions by plans with market power.
Abstract: Medicare beneficiaries are eligible for health insurance through the public option of traditional Medicare (TM) or may join a private Medicare Advantage (MA) plan. Both are highly subsidized but in different ways. Medicare pays for most of costs directly in TM, and subsidizes MA plans based on a “benchmark” for each beneficiary choosing a private plan. The level of this benchmark is arguably the most important policy decision Medicare makes about the MA program. Many analysts recommend equalizing Medicare’s subsidy across the options – referred to in policy circles as a “level playing field.” This paper studies the normative question of how to set the level of the benchmark, applying the versatile model developed by Einav and Finkelstein (EF) to Medicare. The EF framework implies unequal subsidies to counteract risk selection across plan types. We also study other reasons to tilt the field: the relative efficiency of MA vs. TM, market power of MA plans, and institutional features of the way Medicare determines subsidies and premiums. After review of the empirical and policy literature, we conclude that in areas where the MA market is competitive, the benchmark should be set below average costs in TM, but in areas characterized by imperfect competition in MA, it should be raised in order to offset output (enrollment) restrictions by plans with market power. We also recommend specific modifications of Medicare rules to make demand for MA more price elastic.

Summary (2 min read)

1. Introduction

  • A Medicare beneficiary decides between health insurance from the public option of traditional Medicare (TM), or from a private plan offered through the Medicare Advantage (MA) program.
  • This paper addresses arguably the single most important decision Medicare makes about the MA program, setting the benchmark subsidy.
  • The authors main analytical finding in this section, summarized by what the authors refer to as Observation 1, states that with favorable selection into MA and increasing incremental marginal cost in MA, a level-playing field policy is not efficient and leads to too many beneficiaries in MA.
  • Section 5 draws the implications of their analyses.
  • The authors present some of the findings from that paper in their literature review below.

2.1 Medicare Advantage

  • Since 1985, beneficiaries have had the option to choose health insurance through a private plan in Medicare Part C, currently known as Medicare Advantage (MA).
  • If the bid is below the benchmark, the plan must pass the rebate through to beneficiaries in the form of lower premium or increased benefits.
  • Geruso and Layton (2015) find that MA plans code 6-16% higher for the same person as TM, and elevated coding is greatest in the vertically integrated MA plans like HMOs where a plan is in a better position to transmit incentives to providers.
  • By comparing costs conditional on risk score, Curto et al.’s estimate that MA plan enrollees are about 7 percent less costly than TM conditional on risk score captures both differences due to coding practices and differences due to selection.
  • A review of the literature on selection, cost and market power indicates that there is substantial heterogeneity in the nature of MA plans and the market settings in which they find themselves.

3. Sorting Between MA and TM: Application of the Einav-Finkelstein Model

  • The EF model was created to analyze demand-driven risk selection between two plan options with fixed characteristics.
  • The relation of marginal cost curves for MA and TM in Figure 1 reflect any quantity and input price differences between the two sectors.
  • 2 Efficient Enrollment and MA Premium Otherwise, the beneficiary belongs in TM.
  • As is recognized in the literature on health plan choice, no single premium can sort consumers efficiently, given their heterogeneous expected costs, among two plan types.

3.3 Equilibrium Enrollment and MA Premium

  • Equilibrium enrollment depends on the Medicare benchmark, which the authors call R. For now they assume plans are simply paid the benchmark.
  • And of course risk adjustment is not perfect, and leaves opportunities for selection and upcoding.
  • Medicare could ignore the equilibrium condition defining a level playing field and simply set a benchmark equal to average costs in TM as they happen to be at some point in time, but then, because enrollment depends on the benchmark, the resulting equilibrium will not in general satisfy the condition for a “level playing field.”.
  • Thus, the authors know that for every value of qMA, the difference in average costs between MA and TM is greater in absolute value than the difference in marginal costs.

4. Rules for Bidding and Premium Setting: Putting a Kink in Demand for MA

  • This section incorporates some Medicare rules about MA plan bidding and premium setting.
  • At the close of this section the authors assess the evidence supporting the presence of the kink.
  • Bids are supposed to be based on costs and allowable profits but the research literature regards the plans as having sufficient flexibility within the current regulations to choose the bid based on profit maximization.
  • Medicare retains a share of the “savings” if the bid is below the benchmark.
  • Figure 5 shows the original inverse demand, P(qMA), and the kink in the b(qMA) relationship because of the shift in the sharing rule at the enrollent corresponding to p = 0.

4.2 The MA Plan with Market Power with Bidding and Sharing

  • The asymmetric sharing rule is not innocuous when the MA plan has market power.
  • The authors have previously defined marginal cost as MCMA(qMA).
  • Medicare could pay more or less to get to the same enrollment outcome q0.
  • 28 The kinked demand and resulting discontinuous marginal revenue curve predicts a bunching up of equilibrium MA premiums at “zero” premium, i.e., no premium above or below the Part B premium.
  • About 50% of beneficiaries are in plans with exactly a zero premium.

5. Discussion

  • Setting the level of the benchmark subsidy to Medicare Advantage plans is Medicare’s most important decision for managing MA.
  • A level playing field is not a goal, per se, but a policy choice, and their paper shows that once the goal of an efficient MA program is laid out explicitly, the level playing field does not emerge as the policy answer except in a special and unrealistic case.
  • Papers studying where pass through is high and low are informative about the role of market power and the presence of a kink contributing to the story.
  • There are some implications for other health insurance markets, particularly those, like the Marketplaces in the U.S., where there is a ranking of plans (e.g., Gold, Silver, etc.) that is likely to be connected to selection.
  • Beneficiaries who elect TM are attributed to ACOs by an algorithm run by Medicare based on where the beneficiary gets their primary care.

Did you find this useful? Give us your feedback

Citations
More filters
Journal ArticleDOI
TL;DR: These measures of the efficiency consequences of price and benefit distortions under a given payment system are developed based on explicit economic models of insurer behavior under adverse selection, incorporate multiple features of plan payment systems, and can be calculated prior to observing actual insurer and consumer behavior.
Abstract: Adverse selection in health insurance markets leads to two types of inefficiency. On the demand side, adverse selection leads to plan price distortions resulting in inefficient sorting of consumers across health plans. On the supply side, adverse selection creates incentives for plans to inefficiently distort benefits to attract profitable enrollees. Reinsurance, risk adjustment, and premium categories address these problems. Building on prior research on health plan payment system evaluation, we develop measures of the efficiency consequences of price and benefit distortions under a given payment system. Our measures are based on explicit economic models of insurer behavior under adverse selection, incorporate multiple features of plan payment systems, and can be calculated prior to observing actual insurer and consumer behavior. We illustrate the use of these measures with data from a simulated market for individual health insurance.

42 citations

Posted Content
TL;DR: In this paper, the authors study the economics of these "price-linked" subsidies compared to fixed subsidies set independently of market prices and show that price-linked subsidies weaken competition, leading to higher markups and raising costs for the government or consumers.
Abstract: Subsidies in many health insurance programs depend on prices set by competing insurers – as prices rise, so do subsidies. We study the economics of these “price-linked” subsidies compared to “fixed” subsidies set independently of market prices. We show that price-linked subsidies weaken competition, leading to higher markups and raising costs for the government or consumers. However, price-linked subsidies have advantages when insurance costs are uncertain and optimal subsidies increase as costs rise. We evaluate this tradeoff empirically using a model estimated with administrative data from Massachusetts’ health insurance exchange. Relative to fixed subsidies, price-linking increases prices by up to 6% in a market with four competitors, and about twice as much when we simulate markets with two insurers. For levels of cost uncertainty reasonable in a mature market, we find that the losses from higher markups outweigh the benefits of price-linking.

27 citations

Posted Content
TL;DR: It is shown that MA plans have incentives to effectuate risk selection via service-level selection, by lowering coverage levels for services that are more likely to be used by beneficiaries who could be unprofitable under the CMS-HCC model, and estimates that such strategic behavior led MA plans to save $5.2 billion by transferring the costs to the federal government.
Abstract: The Centers for Medicare and Medicaid Services (CMS) has phased in the Hierarchical Condition Categories (HCC) risk adjustment model during 2004-2006 to more accurately estimate capitated payments to Medicare Advantage (MA) plans to reflect each beneficiary’s health status. However, it is debatable whether the CMS-HCC model has led to strategic evolutions of risk selection. We examine the competing claims and analyze the risk selection behavior of MA plans in response to the CMS-HCC model. We find that the CMS-HCC model reduced the phenomenon that MA plans avoid high-cost beneficiaries in traditional Medicare plans, whereas it led to increased disenrollment of high-cost beneficiaries, conditional on illness severity, from MA plans. We explain this phenomenon in relation to service-level selection. First, we show that MA plans have incentives to effectuate risk selection via service-level selection, by lowering coverage levels for services that are more likely to be used by beneficiaries who could be unprofitable under the CMS-HCC model. Then, we empirically test our theoretical prediction that compared to the pre-implementation period (2001-2003), MA plans have raised copayments disproportionately more for services needed by unprofitable beneficiaries than for other services in the post-implementation period (2007-2009). This induced unprofitable beneficiaries to voluntarily dis-enroll from their MA plans. Further evidence supporting this selection mechanism is that those dissatisfied with out-of-pocket costs were more likely to dis-enroll from MA plans. We estimate that such strategic behavior led MA plans to save $5.2 billion by transferring the costs to the federal government.

13 citations


Cites background from "Paying Medicare Advantage plans: To..."

  • ...Also, there is substantial heterogeneity in cost and market power across MA plans (Glazer and McGuire 2016)....

    [...]

Journal ArticleDOI
TL;DR: Two important individual health insurance markets-Medicare Advantage and the Marketplaces-are tightly regulated but rely on competition among insurers to supply and price health insurance products.
Abstract: Two important individual health insurance markets—Medicare Advantage and the Marketplaces—are tightly regulated but rely on competition among insurers to supply and price health insurance products. Many local health insurance markets have little competition, which increases prices to consumers. Furthermore, both markets are highly subsidized in ways that can exacerbate the impact of market power—that is, the ability to set price above cost—on health insurance prices. Policy makers need to foster robust competition in both sectors and avoid designing subsidies that make the market-power problem worse.

11 citations

Posted Content
TL;DR: In this paper, the spillover effects of the Medicare Advantage program on the traditional Medicare program and other patients were explored, taking advantage of changes in Medicare Advantage payment policy to isolate exogenous increases in enrollment and trace out the effects of greater managed care penetration on hospital utilization and spending throughout the health care system.
Abstract: More than a quarter of Medicare beneficiaries are enrolled in Medicare Advantage, which was created in large part to improve the efficiency of health care delivery by promoting competition among private managed care plans. This paper explores the spillover effects of the Medicare Advantage program on the traditional Medicare program and other patients, taking advantage of changes in Medicare Advantage payment policy to isolate exogenous increases in Medicare Advantage enrollment and trace out the effects of greater managed care penetration on hospital utilization and spending throughout the health care system. We find that when more seniors enroll in Medicare managed care, hospital costs decline for all seniors and for commercially insured younger populations. Greater managed care penetration is not associated with fewer hospitalizations, but is associated with lower costs and shorter stays per hospitalization. These spillovers are substantial - offsetting more than 10% of increased payments to Medicare Advantage plans.

11 citations

References
More filters
Journal ArticleDOI
TL;DR: In this article, the authors examined how tolls change after toll facilities adopt electronic toll collection (ETC); they found that drivers are substantially less aware of tolls paid electronically.
Abstract: This paper examines whether the salience of a tax system affects equilibrium tax rates. I analyze how tolls change after toll facilities adopt electronic toll collection (ETC); drivers are substantially less aware of tolls paid electronically. I estimate that, in steady state, tolls are 20 to 40 percent higher than they would have been without ETC. Consistent with a salience-based explanation for this toll increase, I find that under ETC, driving becomes less elastic with respect to the toll and toll setting becomes less sensitive to the electoral calendar. Alternative explanations appear unlikely to be able to explain the findings.

546 citations

Book ChapterDOI
TL;DR: The anatomy of health insurance can be found in this article, where the authors consider the optimal design of a health insurance policy that makes tradeoffs appropriately between risk sharing on the one hand and agency problems such as moral hazard and supplier-induced demand on the other.
Abstract: This article describes the anatomy of health insurance. It begins by considering the optimal design of health insurance policies. Such policies must make tradeoffs appropriately between risk sharing on the one hand and agency problems such as moral hazard (the incentive of people to seek more care when they are insured) and supplier-induced demand (the incentive of physicians to provide more care when they are well reimbursed) on the other. Optimal coinsurance arrangements make patients pay for care up to the point where the marginal gains from less risk sharing are just offset by the marginal benefits from reduced provision of low valued care. Empirical evidence shows that both moral hazard and demand-inducement are quantitatively important. Coinsurance based on expenditure is a crude control mechanism. Moreover, it places no direct incentives on physicians, who are responsible for most expenditure decisions. To place such incentives on physicians is the goal of supply-side cost containment measures, such as utilization review and capitation. This goal motivates the surge in managed care in the United States, which unites the functions of insurance and provision, and allows for active management of the care that is delivered. The analysis then turns to the operation of health insurance markets. Economists generally favor choice in health insurance for the same reasons they favor choice in other markets: choice allows people to opt for the plan that is best for them and encourages plans to provide services efficiently. But choice in health insurance is a mixed blessing because of adverse selection – the tendency of the sick to choose more generous insurance than the healthy. When sick and healthy enroll in different plans, plans disproportionately composed of poor risks have to charge more than they would if they insured an average mix of people. The resulting high premiums create two adverse effects: they discourage those who are healthier but would prefer generous care from enrolling in those plans (because the premiums are so high), and they encourage plans to adopt measures that deter the sick from enrolling (to reduce their overall costs). The welfare losses from adverse selection are large in practice. Added to them are further losses from premiums that vary with observable health status. Because insurance is contracted for annually, people are denied a valuable form of intertemporal insurance – the right to buy health coverage at average rates in the future should they get sick today. As the ability to predict future health status increases, the lack of intertemporal insurance will become more problematic. The article concludes by relating health insurance to the central goal of medical care expenditures – better health. Studies to date are not clear on which approaches to health insurance promote health in the most cost-efficient manner. Resolving this question is the central policy concern in health economics.

540 citations

Journal ArticleDOI
TL;DR: As it is outlined here, managed competition as a means to reform the U.S. health care system is compatible with Americans' preferences for pluralism, individual choice and responsibility, and universal coverage.
Abstract: Prologue: Health policymakers listening to presidential candidate Bill Clinton's proposals for health system reform may have felt a sense of deja vu as he returned time and again to the theme of “managed competition' in his speeches. The term was familiar to many who had been following the speaking and writing of Alain Enthoven as he refined and articulated the concept. In Enthoven's construct, managed competition relies on a sponsor to structure and adjust the market for competing health plans, to establish equitable rules, create price-elastic demand, and avoid uncompensated risk selection. That sponsor could take the form of a health insurance purchasing cooperative, or HIPC, comprising members of the employer and consumer communities. Enthoven's definition of managed competition is a blending of the competitive and regulatory strategies that have coexisted uneasily for years in the U.S. health care system. As happens with many concepts that become election-year rhetoric, managed competition has come t...

532 citations

Journal ArticleDOI
TL;DR: For example, the authors found that when faced with a choice of selecting one of several available products or possibly buying nothing, according to standard theoretical perspectives, people will choose the option with the highest cost-benefit difference.
Abstract: When faced with a choice of selecting one of several available products or possibly buying nothing, according to standard theoretical perspectives, people will choose the option with the highest cost--benefit difference. However, we propose that decisions about free zero price products differ, in that people do not simply subtract costs from benefits but instead they perceive the benefits associated with free products as higher. We test this proposal by contrasting demand for two products across conditions that maintain the price difference between the goods, but vary the prices such that the cheaper good in the set is priced at either a low positive or zero price. In contrast with a standard cost--benefit perspective, in the zero-price condition, dramatically more participants choose the cheaper option, whereas dramatically fewer participants choose the more expensive option. Thus, people appear to act as if zero pricing of a good not only decreases its cost, but also adds to its benefits. After documenting this basic effect, we propose and test several psychological antecedents of the effect, including social norms, mapping difficulty, and affect. Affect emerges as the most likely account for the effect.

504 citations

Posted Content
TL;DR: In this article, the authors used data on health insurance choices by employees of Harvard University to examine the effect of alternative pricing rules on market equilibrium and found that the long-run demand response is three times the short-run response.
Abstract: This paper uses data on health insurance choices by employees of Harvard University to examine the effect of alternative pricing rules on market equilibrium In the mid-1990s, Harvard moved from a system of subsidizing more expensive insurance to a system of contributing an equal amount to each plan We estimate a substantial demand response to the policy change, with a short-run elasticity of about -2 The reform also induced substantial" adverse selection Because of this selection, the long-run demand response is three times the short-run response Price variation induced by adverse selection is inefficient; we estimate the magnitude of the welfare loss from adverse selection at 2 percent of baseline health spending Finally, as insurance choice was made more competitive, premiums to Harvard fell relative to premiums in the Boston area by nearly 10 percent This savings was large enough to compensate for the inefficiency induced by adverse selection, so that reform overall was welfare enhancing

467 citations


"Paying Medicare Advantage plans: To..." refers methods in this paper

  • ...The EF approach builds on earlier work by Cutler and Reber (1998)....

    [...]

Frequently Asked Questions (1)
Q1. What have the authors contributed in "Paying medicare advantage plans: to level or tilt the playing field" ?

Many analysts recommend equalizing Medicare ’ s subsidy across the options – referred to in policy circles as a “ level playing field. ” This paper studies the normative question of how to set the level of the benchmark, applying the versatile model developed by Einav and Finkelstein ( EF ) to Medicare. The authors also study other reasons to tilt the field: the relative efficiency of MA vs. TM, market power of MA plans, and institutional features of the way Medicare determines subsidies and premiums. Acknowledgements: Research for this paper was supported by the National Institute of Aging ( P01-AG032952 ). The first author would like also to thank the Henry Crown Institute of Business Research in Israel at Tel Aviv University for its financial support. The authors are grateful to Mike Chernew, Liran Einav, Randy Ellis, Amy Finkelstein, Bruce Landon, Tim Layton, Eran Politzer, Michael McWilliams, Joseph Newhouse and Richard van Kleef for helpful discussion. The views in the paper are the authors ’ own.